These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8579881)

  • 1. An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).
    Alexander DJ; Libretto SE
    Hum Exp Toxicol; 1995 Sep; 14(9):715-20. PubMed ID: 8579881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFA-134a (1,1,1,2-tetrafluoroethane); lack of oncogenicity in rodents after inhalation.
    Alexander DJ; Libretto SE; Chevalier HJ; Imamura T; Pappritz G; Wilson J
    Hum Exp Toxicol; 1995 Sep; 14(9):706-14. PubMed ID: 8579880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute, repeated inhalation toxicity, respiratory system irritation, and mutagenicity studies of 1,1,2,2-tetrafluoroethane (HFC-134) as the impurity in the pharmaceutical propellant 1,1,1,2-tetrafluoroethane (HFA-134a).
    Zhao Y; Sun H; Lin F; Yang H
    Drug Chem Toxicol; 2023 Nov; 46(5):841-850. PubMed ID: 35920286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFC replacements: safety testing, approval for use in metered dose inhalers.
    Graepel P; Alexander DJ
    J Aerosol Med; 1991; 4(3):193-200. PubMed ID: 10147679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
    Shin HW; Barletta B; Yoonessi L; Meinardi S; Leu SY; Radom-Aizik S; Randhawa I; Nussbaum E; Blake DR; Cooper DM
    Clin Transl Sci; 2015 Oct; 8(5):445-50. PubMed ID: 26155923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure.
    Emmen HH; Hoogendijk EM; Klöpping-Ketelaars WA; Muijser H; Duistermaat E; Ravensberg JC; Alexander DJ; Borkhataria D; Rusch GM; Schmit B
    Regul Toxicol Pharmacol; 2000 Aug; 32(1):22-35. PubMed ID: 11029265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of propellants.
    Alexander DJ
    J Aerosol Med; 1995; 8 Suppl 1():S29-34. PubMed ID: 10150492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects.
    Harrison LI; Donnell D; Simmons JL; Ekholm BP; Cooper KM; Wyld PJ
    J Pharm Pharmacol; 1996 Jun; 48(6):596-600. PubMed ID: 8832493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
    Ju D; Shrimpton J; Hearn A
    Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFA-134a (1,1,1,2-tetrafluoroethane): effects of inhalation exposure upon reproductive performance, development and maturation of rats.
    Alexander DJ; Libretto SE; Adams MJ; Hughes EW; Bannerman M
    Hum Exp Toxicol; 1996 Jun; 15(6):508-17. PubMed ID: 8793535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.
    Hoe S; Young PM; Rogueda P; Traini D
    AAPS PharmSciTech; 2008; 9(2):605-11. PubMed ID: 18459053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays.
    Reid ML; Benaouda F; Khengar R; Jones SA; Brown MB
    Int J Pharm; 2013 Aug; 452(1-2):157-65. PubMed ID: 23684656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
    Leach CL; Colice GL
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in metered dose inhaler propellants].
    Chinet T
    Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.